About Sodiumhyaluronatemanufacturers
Sodiumhyaluronatemanufacturers is a Consumer company. It delivers enzyme and probiotic solutions for industrial applications in biopharmaceuticals and cosmetics. It operates on a B2B model in Consumer and Healthcare sectors. Its Indian entity Fido Pharma Private Limited reported revenue of ₹20.59 Cr. Sodiumhyaluronatemanufacturers offers products and services including Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements. Its focus areas include Cosmetics, Nutraceuticals, Dietary Supplements and Biopharmaceuticals.
Company details
Fido Pharma Private Limited specializes in developing and supplying enzyme solutions and probiotics for sectors like biopharmaceuticals, fine chemicals, food and feed, and cosmetics. The company operates from its head office in Panchkula, India, with manufacturing facilities in Hyderabad and Panchkula. They focus on high-quality products such as sodium hyaluronate for skincare and other applications, serving various customer needs in these industries through reliable distribution.
- SectorsConsumerHealthcare
- Email••••••••
- Phone•••• ••••
- Website sodiumhyaluronatemanufacturers.com
- Legal Name Fido Pharma Private Limited
- Date of Incorporation 04 Mar, 2020
- Jurisdiction Panchkula, Haryana, India
- Indian entity revenue₹20.59 Cr
FY 2024 · +190% YoY
- Indian entity net profit₹4.07 Cr
FY 2024 · 20% margin
- Indian entity EBITDA₹4.89 Cr
FY 2024 · 24% margin
Associated legal entities of Sodiumhyaluronatemanufacturers
Sodiumhyaluronatemanufacturers operates through Fido Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Fido Pharma Private Limited CIN U24230HR2020PTC085725 | Active | 04 Mar 2020 | Panchkula, Haryana | ₹20.6 Cr | 3 | View details |
Products & Services of Sodiumhyaluronatemanufacturers
Sodiumhyaluronatemanufacturers offers a comprehensive portfolio of products and services, including Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements.
Solutions for biopharmaceutical and industrial applications
Products for food, feed, and cosmetics industries
Blended solutions for health and biopharmaceutical uses
Supplements including sodium hyaluronate for skincare
Formulations for consumer and industrial health needs
Board of directors of Fido Pharma Private Limited (Sodiumhyaluronatemanufacturers)
Fido Pharma Private Limited is the primary company behind Sodiumhyaluronatemanufacturers. The board of Fido Pharma Private Limited currently have 3 directors; the longest-serving is Tejal Ashok Vispute, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tejal Ashok Vispute DIN 08717158 | Director | 04 Mar 2020 | 6 yrs 7 mo | Fido Pharma Private Limited |
| Parbhat Singh DIN 08717156 | Director | 04 Mar 2020 | 6 yrs 7 mo | Fido Pharma Private Limited |
| Ritu Raj Singh DIN 10186291 | Director | 30 May 2023 | 3 yrs 4 mo | Fido Pharma Private Limited |
Financials of Sodiumhyaluronatemanufacturers
Figures of Fido Pharma Private Limited, the primary company behind Sodiumhyaluronatemanufacturers, for FY 2024. Revenue was ₹20.59 Cr (+190% year on year). Net profit was ₹4.07 Cr (20% margin). EBITDA was ₹4.89 Cr (24% margin). Revenue has grown at a compounded annual rate of +114% over three years.
- ₹20.59 CrRevenue · FY 2024 · +190% YoY
- ₹4.07 CrNet profit · 20% margin
- ₹4.89 CrEBITDA · 24% margin
- ₹50 LakhPaid-up capital
- +114%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Fido Pharma Private Limited are on its company page.
Detailed financial statements for Sodiumhyaluronatemanufacturers
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sodiumhyaluronatemanufacturers
The primary company behind Sodiumhyaluronatemanufacturers, Fido Pharma Private Limited, reported revenue of ₹20.59 Cr for FY 2024, up 190% year on year.
Fido Pharma Private Limited specializes in developing and supplying enzyme solutions and probiotics for sectors like biopharmaceuticals, fine chemicals, food and feed, and cosmetics. The company operates from its head office in Panchkula, India, with manufacturing facilities in Hyderabad and Panchkula. They focus on high-quality products such as sodium hyaluronate for skincare and other applications, serving various customer needs in these industries through reliable distribution.
Sodiumhyaluronatemanufacturers offers Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements.
Sodiumhyaluronatemanufacturers operates through Fido Pharma Private Limited.
The legal entities of Sodiumhyaluronatemanufacturers currently have 3 directors, including Tejal Ashok Vispute, Parbhat Singh, Ritu Raj Singh.